Campus, Miralyn .

HRN: 27-29-25  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
CEFUROXIME 1.5GM (VIAL)
06/09/2025
06/09/2025
IVT
1.5 G
PTOR
STAT CS
Checking Initial Appropriateness 
06/11/2025
CEFUROXIME 1.5GM (VIAL)
06/11/2025
06/13/2025
IV
1.5
Q8
SP LTCS
Remove - Pending Acceptance
06/11/2025
MUPIROCIN 2%, 15G (TUBE)
06/11/2025
06/15/2025
TOPICAL
Apply On Surgical Site
Daily
Post Op Prophylaxis
Checking Initial Appropriateness 
06/13/2025
CEFUROXIME 500MG (TAB)
06/13/2025
06/19/2025
PO
500mg
BID
CS
Remove - Pending Acceptance
06/16/2025
CEFUROXIME 500MG (TAB)
06/16/2025
06/20/2025
PO
500mg
BID
SP CS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: